Loading…
Sectoral / Thematic · WhiteOak Capital Mutual Fund · AMFI code 152348WhiteOak Capital Pharma and Healthcare Fund
Disclosed for 2 months, Aug 2026 to Sep 2026.
Portfolio value
₹927 Cr
up ₹24.3 Cr vs Aug 2026
- Stocks held
- 50
- unchanged
- Top 10 weight
- 44.6%
- of the portfolio in its ten largest
- Cash & debt
- 9.3%
- cash, money market and debt
- Moves this month
- 3 in · 3 out
- added to 10, trimmed 23
WhiteOak Capital Pharma and Healthcare Fund is an active equity fund in the Sectoral / Thematic category from WhiteOak Capital Mutual Fund. In September 2026 it disclosed 50 stocks worth ₹927 Cr, up ₹24.3 Cr from Aug 2026. Its largest positions were Divi's Laboratories Limited (8.4%), Sun Pharmaceutical Industries Limited (7.1%), Torrent Pharmaceuticals Limited (6.3%); the ten largest together made up 44.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.4% of its equity. Cash and debt stood at 9.3%. Compared with Aug 2026 the fund entered 3 new stocks and exited 3.
Against 226 other Sectoral / Thematic funds
Concentration
45%
Top-10 weight is higher than 45% of peers
Breadth
64%
Holds more stocks than 64% of peers
Cash
93%
Holds more cash than 93% of peers
Holdings in September 2026
Download CSVEvery line the fund disclosed, with the change against Aug 2026. Click a column to sort; click a company to see every fund that owns it.
| Divi's Laboratories Limited | 8.36% | down 0.08 pts | ₹77.5 Cr | up ₹1.3 Cr | Added |
| Sun Pharmaceutical Industries Limited | 7.11% | down 0.29 pts | ₹65.9 Cr | down ₹89 L | Trimmed |
| Torrent Pharmaceuticals Limited | 6.26% | down 0.52 pts | ₹58 Cr | down ₹3.2 Cr | Trimmed |
| Cash, TREPS & receivables | 6.12% | up 2.27 pts | ₹56.7 Cr | up ₹22 Cr | Added |
| Laurus Labs Limited | 3.91% | up 0.13 pts | ₹36.2 Cr | up ₹2.1 Cr | Added |
| Apollo Hospitals Enterprise Limited | 3.75% | down 0.98 pts | ₹34.8 Cr | down ₹7.9 Cr | Trimmed |
| Cipla Limited | 3.68% | up 0.42 pts | ₹34.1 Cr | up ₹4.7 Cr | Added |
| Sai Life Sciences Limited | 3.28% | down 0.04 pts | ₹30.4 Cr | up ₹40 L | Added |
| IPCA Laboratories Limited | 2.88% | up 0.22 pts | ₹26.7 Cr | up ₹2.7 Cr | Added |
| Zydus Lifesciences Limited | 2.81% | up 0.23 pts | ₹26.1 Cr | up ₹2.8 Cr | Added |
| Neuland Laboratories Limited | 2.60% | down 0.28 pts | ₹24.1 Cr | down ₹1.9 Cr | Trimmed |
| Dr. Lal Path Labs Limited | 2.35% | up <0.01 pts | ₹21.8 Cr | up ₹57 L | Added |
| Corona Remedies Limited | 2.34% | down 0.01 pts | ₹21.6 Cr | up ₹45 L | Added |
| Thyrocare Technologies Limited | 2.27% | down 0.04 pts | ₹21.1 Cr | up ₹24 L | Added |
| Aurobindo Pharma Limited | 2.09% | down 0.11 pts | ₹19.4 Cr | down ₹52 L | Trimmed |
| Ajanta Pharma Limited | 2.01% | up 0.29 pts | ₹18.6 Cr | up ₹3.1 Cr | Added |
| Krishna Institute Of Medical Sciences Limited | 1.85% | down 0.07 pts | ₹17.1 Cr | down ₹21 L | Trimmed |
| Max Healthcare Institute Limited | 1.84% | down 1.21 pts | ₹17.1 Cr | down ₹10.4 Cr | Trimmed |
| Shaily Engineering Plastics Limited | 1.84% | down 0.18 pts | ₹17 Cr | down ₹1.2 Cr | Trimmed |
| Global Health Limited | 1.82% | down 0.10 pts | ₹16.9 Cr | down ₹48 L | Trimmed |
| Narayana Hrudayalaya Limited | 1.61% | down 0.15 pts | ₹14.9 Cr | down ₹97 L | Trimmed |
| Anthem Biosciences Limited | 1.57% | down 0.11 pts | ₹14.6 Cr | down ₹58 L | Trimmed |
| Vijaya Diagnostic Centre Limited | 1.56% | down 0.03 pts | ₹14.4 Cr | up ₹12 L | Added |
| Onesource Specialty Pharma Limited | 1.55% | up 0.54 pts | ₹14.4 Cr | up ₹5.2 Cr | Added |
| Acutaas Chemicals Limited | 1.45% | up 0.01 pts | ₹13.5 Cr | up ₹49 L | Added |
| Navin Fluorine International Limited | 1.41% | down 0.11 pts | ₹13.1 Cr | down ₹68 L | Trimmed |
| Fortis Healthcare Limited | 1.36% | down 0.29 pts | ₹12.6 Cr | down ₹2.2 Cr | Trimmed |
| Aarti Pharmalabs Limited | 1.20% | up 0.11 pts | ₹11.2 Cr | up ₹1.3 Cr | Added |
| Mankind Pharma Limited | 1.20% | up 1.20 pts | ₹11.1 Cr | up ₹11.1 Cr | New |
| Procter & Gamble Health Limited | 1.18% | down 0.08 pts | ₹10.9 Cr | down ₹40 L | Trimmed |
| MOLBIO DIAGNOSTICS LIMITED | 1.15% | up 0.17 pts | ₹10.7 Cr | up ₹1.8 Cr | Added |
| Rainbow Childrens Medicare Limited | 1.15% | down 0.12 pts | ₹10.6 Cr | down ₹81 L | Trimmed |
| Piramal Pharma Limited | 1.06% | up 1.06 pts | ₹9.8 Cr | up ₹9.8 Cr | New |
| Aether Industries Ltd. | 1.05% | up 0.08 pts | ₹9.7 Cr | up ₹99 L | Added |
| Kovai Medical Center and Hospital Limited | 0.95% | down 0.04 pts | ₹8.8 Cr | down ₹10 L | Trimmed |
| Gland Pharma Limited | 0.93% | up 0.08 pts | ₹8.6 Cr | up ₹93 L | Added |
| Senores Pharmaceuticals Limited | 0.80% | down 0.05 pts | ₹7.4 Cr | down ₹25 L | Trimmed |
| Jupiter Life Line Hospitals Limited | 0.73% | down 0.14 pts | ₹6.8 Cr | down ₹1.1 Cr | Trimmed |
| Supriya Lifescience Limited | 0.69% | up 0.10 pts | ₹6.4 Cr | up ₹1 Cr | Added |
| Vimta Labs Limited | 0.67% | down 0.07 pts | ₹6.2 Cr | down ₹44 L | Trimmed |
| Innova Captab Limited | 0.63% | up 0.03 pts | ₹5.9 Cr | up ₹41 L | Added |
| 91 Days Tbill (MD Debt | 0.60% | down 0.01 pts | ₹5.6 Cr | up ₹2 L | Held |
| 91 Days Treasury Bill 03-Dec-2026 Debt | 0.60% | up 0.60 pts | ₹5.5 Cr | up ₹5.5 Cr | New |
| Nephrocare Health Services Ltd | 0.57% | down 0.04 pts | ₹5.3 Cr | down ₹19 L | Trimmed |
| 91 Days Tbill (MD Debt | 0.53% | up 0.53 pts | ₹4.9 Cr | up ₹4.9 Cr | New |
| Manipal Health Enterprises Ltd | 0.52% | down 0.63 pts | ₹4.8 Cr | down ₹5.5 Cr | Trimmed |
| 182 Days Tbill (MD Debt | 0.47% | down 0.01 pts | ₹4.4 Cr | up ₹2 L | Held |
| Sudeep Pharma Limited | 0.46% | down 0.01 pts | ₹4.2 Cr | down ₹1 L | Held |
| Biocon Limited | 0.42% | down 0.06 pts | ₹3.9 Cr | down ₹44 L | Trimmed |
| Tatva Chintan Pharma Chem Limited | 0.42% | up 0.03 pts | ₹3.8 Cr | up ₹34 L | Added |
What changed, Aug 2026 to Sep 2026
New New positions (3)
- Mankind Pharma Limited1.2% · ₹11.1 Cr
- Piramal Pharma Limited1.1% · ₹9.8 Cr
- Novartis India Limited0.2% · ₹2.2 Cr
Exited Exited (3)
- Pfizer Limitedwas 1.1% · ₹10.3 Cr
- Poly Medicure Limitedwas 0.8% · ₹6.9 Cr
- Suven Pharmaceuticals Limitedwas 0.2% · ₹1.9 Cr
Added Biggest additions
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2026, the weight rose most in Pharmaceuticals & Biotechnology (+4.0 pts), and fell most in Healthcare Services (−3.4 pts) and Healthcare Equipment & Supplies (−0.6 pts).
- Pharmaceuticals & Biotechnology63.4% → 67.4%+4.0 pts
- Healthcare Services28.7% → 25.4%−3.4 pts
- Healthcare Equipment & Supplies2.1% → 1.5%−0.6 pts
- Consumer Durables2.2% → 2.0%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2026 | Sep 2026 |
|---|---|---|
| Pharmaceuticals & Biotechnology | 63.4% | 67.4% |
| Healthcare Services | 28.7% | 25.4% |
| Chemicals & Petrochemicals | 3.6% | 3.7% |
| Consumer Durables | 2.2% | 2.0% |
| Healthcare Equipment & Supplies | 2.1% | 1.5% |
Allocation in Sep 2026change vs Aug 2026
- Pharmaceuticals & Biotechnology (28)67.4%▲ 4.0 pts
- Healthcare Services (15)25.4%▼ 3.4 pts
- Chemicals & Petrochemicals (4)3.7%▲ 0.1 pts
- Consumer Durables (1)2.0%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Sep 2026
9.3%
▲ 2.9 pts vs Aug 2026
- Cash alone
- 6.1%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 6.4% – 9.3%
- lowest to highest · record 9.3% in Sep 2026
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.